Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As the systems we use to deliver software to the cloud get more complex and reliant on third ...

Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran (nex-z, formerly known as NTLA-2001) for the treatment of transthyretin ...

When Apple’s App Store opened its digital doors for business in 2008 to third-party developers, it launched with just 500 apps. In the early years of mobile, developing mobile apps was the domain of ...

CEO Ken Galbraith highlighted the company’s progress in advancing its R&D pipeline, emphasizing milestones such as six poster presentations at AACR and the nearing IND submission for ZW251 by mid-2025 ...

CHENGDU, China and GEMBLOUX, Belgium, Sept. 29, 2025 /PRNewswire/ -- Full-Life Technologies ("Full-Life", the "Company"), a fully-integrated global radiotherapeutics company, today announced the ...